Costs and quality of life associated with acute upper gastrointestinal bleeding in the UK: cohort analysis of patients in a cluster randomised trial

BMJ Open

Volumn 5, Issue 4, 2015, Pages

  Campbell, H E ^a   Stokes, E A ^a   Bargo, D ^a   Logan, R F ^b   Mora, A ^c   Hodge, R ^c   Gray, A ^d   James, M W ^b   Stanley, A J ^e   Everett, S M ^f   Bailey, A A ^g   Dallal, H ^h   Greenaway, J ^h   Dyer, C ^c   Llewelyn, C ^c   Walsh, T S ⁱ   Travis, S P L ^g   Murphy, M F ^c,j   Jairath, V ^c,g   Kahan, Brennan ^k   Walt, Bob ^k   Turner, Marc ^k   Wheatley, Keith ^k   Wyncoll, Duncan ^k   Benger, Jonathan ^k   Doré, Caroline ^k   Gorton, Cliff ^k   Meredith, Sarah ^k   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

^d ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^e GLASGOW ROYAL INFIRMARY   (United Kingdom)

^f ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF EDINBURGH   (United Kingdom)

^j NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

^k NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMICS; ENDOSCOPY; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL HEMORRHAGE; GREAT BRITAIN; HEALTH CARE COST; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MULTICENTER STUDY; PROSPECTIVE STUDY; PSYCHOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STATISTICS AND NUMERICAL DATA;

ACUTE DISEASE; COST-BENEFIT ANALYSIS; ENDOSCOPY; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL HEMORRHAGE; GREAT BRITAIN; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 84983204566     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/BMJOPEN-2014-007230     Document Type: Article

References (25)

1. Crooks C, Card T, West J. Reductions in 28-day mortality following hospital admission for upper gastrointestinal hemorrhage. Gastroenterology 2011;141:62-70.
2. Parker DR, Luo X, Jalbert J, et al. Impact of upper and lower gastrointestinal blood loss on healthcare utilization and costs: a systematic review. J Med Econ 2011;14:279-87.
3. Kahan BC, Jairath V, Murphy MF, et al. Update on the transfusion in gastrointestinal bleeding (TRIGGER) trial: statistical analysis plan for a cluster-randomised feasibility trial. Trials 2013;14:206.
4. Jairath V, Kahan BC, Gray A, et al. Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trial. Transfus Med Rev 2013;27:146-53.
5. Jairath V, Kahan BC, Gray A, et al. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding: pragmatic, cluster randomised feasibility trial. Lancet 2014. In Press.
6. Department of Health. NHS National Schedule of Reference Costs 2012-13. https://www.gov.uk/government/publications/nhsreference-costs-2012-to-2013 (accessed 12 Jan 2014).
7. NHS Blood and Transplant. Price list 2012/2013. NHS Blood and Transplant, 2012.
8. Department of Health Commercial Medicines Unit. Electronic Market Information Tool. https://www.gov.uk/government/publications/drugs- and-pharmaceutical-electronic-market-information-emit (accessed 12 Jan 2014).
9. Curtis L. Unit costs of health and social care 2013. Canterbury: Personal and Social Services Research Unit University of Kent, 2013.
10. Bovill D. Patterns of pay: estimates from the Annual Survey of Hours and Earnings, UK, 1997 to 2013. http://www.ons.gov.uk/ons/dcp171766_353368.pdf (accessed 1 May 2014).
11. Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53-72.
12. Dolan P, Gudex C, Kind P, et al. A social tariff for EuroQol: results from a UK General Population Survey (Discussion Paper No. 138). York, England: Centre for Health Economics University of York, 1995.
13. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095-108.
14. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011;30:377-99.
15. Briggs A, Clark T, Wolstenholme J, et al. Missing…presumed at random: cost-analysis of incomplete data. Health Econ 2003;12:377-92.
16. Ng ES-W, Diaz-Ordaz K, Grieve R, et al. Multilevel models for cost-effectiveness analyses that use cluster randomised trial data: an approach to model choice. Stat Methods Med Res 2013 Published Online First.
17. Gomes M, Ng ES-W, Grieve R, et al. Developing appropriate methods for cost-effectiveness analysis of cluster randomized trials. Med Decis Making 2012;32:350-61.
18. Rockall TA, Logan RF, Devlin HB, et al. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. BMJ 1995;311:222-6.
19. Office for National Statistics. Population estimates for UK, England and Wales, Scotland and Northern Ireland, Mid-2012. http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm% 3A77-319259 (accessed 6 Jun 2014).
20. Hearnshaw SA, Logan RFA, Lowe D, et al. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut 2011;60:1327-35.
21. Szende A, Janssen B. Population norms for the EQ-5D. In: Szende A, Janssen B, Cabases J, eds. Self-reported population health: an international perspective based on EQ-5D. New York: Springer, 2014:19-30.
22. National Audit Office. Healthcare across the UK: a comparison of the NHS in England, Scotland, Wales and Northern Ireland. London: The Stationary Office, 2012.
23. Jairath V, Kahan BC, Logan RFA, et al. Outcomes following acute nonvariceal upper gastrointestinal bleeding in relation to time to endoscopy: results from a nationwide study. Endoscopy 2012;44:723-30.
24. Leontiadis GI, Sreedharan A, Dorward S, et al. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technol Assess Rep 2007;11:1-164.
25. Díaz-Ordaz K, Kenward MG, Grieve R. Handling missing values in cost effectiveness analyses that use data from cluster randomized trials. J R Stat Soc A 2014;177:457-74.